Pathfinder Medical is developing an electronic guidance system that facilitates safe needle crossing and guidewire placement across blood vessels for minimally invasive vascular procedures. This technology provides a reliable method for patients to receive haemodialysis and bypass arterial blockages, addressing significant clinical needs in a £4.2 billion annual market.
Funding
$11.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BGFounders
Product
Problem
Crossing and placing guidewires safely across blood vessels during minimally invasive vascular procedures can be challenging, potentially leading to complications. Current methods may lack precision, increasing the risk of vessel damage and procedural failures. This is particularly critical in procedures like creating arteriovenous fistulas for hemodialysis and bypassing arterial blockages.
Solution
Pathfinder Medical is developing an electronic guidance system designed to improve the safety and reliability of needle crossing and guidewire placement in endovascular procedures. Their technology aims to provide clinicians with enhanced precision when connecting blood vessels in a minimally invasive manner. The platform is intended to reduce complications and improve outcomes for patients requiring vascular access for hemodialysis or arterial bypass procedures. By offering a more controlled and accurate approach, Pathfinder Medical seeks to address the limitations of existing techniques.
Target Audience
The primary target audience includes clinicians performing minimally invasive vascular procedures, such as vascular surgeons and interventional radiologists.
Features
- Electronic guidance system for precise needle crossing and guidewire placement.
- Minimally invasive approach to connecting blood vessels.
- Assistive technology applicable to multiple vascular indications.